Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.
The Mitochondrion as an Emerging Therapeutic Target in Cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Mitochondrion as an Emerging Therapeutic Target in Cancer.
The Mitochondrion as an Emerging Therapeutic Target in Cancer. Trends Mol Med. 2020 01; 26(1):119-134.
View in:
PubMed
subject areas
Animals
Energy Metabolism
Glycolysis
Humans
Mitochondria
Neoplasms
Oxidative Phosphorylation
Tumor Microenvironment
authors with profiles
Ravi Salgia